| Download the amazing global Makindo app: Android | Apple | |
|---|---|
| MEDICAL DISCLAIMER: Educational use only. Not for diagnosis or management. See below for full disclaimer. |
โ ๏ธ Early diagnosis of Anthrax and the prompt initiation of combination antimicrobial therapy are critical for survival. ๐จ Inhalational anthrax, in particular, carries a high mortality if untreated and requires immediate critical care involvement.
| Scenario | Drug & Dose |
|---|---|
| ๐๏ธ Cutaneous Anthrax (mild, non-systemic) |
Ciprofloxacin 500 mg PO BD (7โ10 days)
OR
Doxycycline 100 mg PO BD (7โ10 days)
๐ก If systemic features โ use IV + combination therapy. |
| ๐จ Inhalational Anthrax / Systemic infection |
Ciprofloxacin 400 mg IV every 12h
OR
Doxycycline 100 mg IV every 12h
โ Add 1โ2 additional agents (rifampicin, clindamycin, or aminoglycoside) for synergy. Duration: โฅ60 days (due to persistent spores). |
| ๐ง Anthrax meningitis (suspected/confirmed) | Ciprofloxacin IV (as above) โ Rifampicin IV โ Clindamycin IV (Triple therapy recommended). |
| ๐งด Post-exposure prophylaxis (PEP) |
Ciprofloxacin 500 mg PO BD for 60 days
OR
Doxycycline 100 mg PO BD for 60 days.
โ Anthrax vaccine where available. |